about
Recent Advances in Discovering the Role of CCL5 in Metastatic Breast CancerSafety of Nanoparticles in MedicineLive-cell single-molecule imaging reveals clathrin and caveolin-1 dependent docking of SMAD4 at the cell membrane.Cyclodextrin and polyethylenimine functionalized mesoporous silica nanoparticles for delivery of siRNA cancer therapeutics.Polyarginine induces an antitumor immune response through binding to toll-like receptor 4.Differences in the aerobic capacity of flight muscles between butterfly populations and species with dissimilar flight abilitiesThe nano-plasma interface: Implications of the protein corona.Multifunctional gold nanorods for siRNA gene silencing and photothermal therapy.Evaluation of anticancer activity of celastrol liposomes in prostate cancer cells.Porous silicon microparticles for delivery of siRNA therapeutics.Connective tissue growth factor stimulates the proliferation, migration and differentiation of lung fibroblasts during paraquat-induced pulmonary fibrosisMultistage vector (MSV) therapeutics.Hesperetin: an inhibitor of the transforming growth factor-β (TGF-β) signaling pathway.A Micro/Nano Composite for Combination Treatment of Melanoma Lung MetastasisLabel-Free Isothermal Amplification Assay for Specific and Highly Sensitive Colorimetric miRNA DetectionHesperetin impairs glucose uptake and inhibits proliferation of breast cancer cells.High capacity nanoporous silicon carrier for systemic delivery of gene silencing therapeutics.Shrinkage of pegylated and non-pegylated liposomes in serumPolyethylenimine and chitosan carriers for the delivery of RNA interference effectors.Liposomal chemotherapeutics.Safety of Nanoparticles in Medicine.Hesperetin Liposomes for Cancer Therapy.Protective effects of intestinal trefoil factor (ITF) on gastric mucosal epithelium through activation of extracellular signal-regulated kinase 1/2 (ERK1/2).Strategies for improving drug delivery: nanocarriers and microenvironmental priming.Anticancer activity of liposomal bergamot essential oil (BEO) on human neuroblastoma cells.Post-nano strategies for drug delivery: Multistage porous silicon microvectors.A pyruvate decarboxylase-mediated therapeutic strategy for mimicking yeast metabolism in cancer cells.A chloroquine-induced macrophage-preconditioning strategy for improved nanodelivery.Enzyme-responsive multistage vector for drug delivery to tumor tissue.A Liposome Encapsulated Ruthenium Polypyridine Complex as a Theranostic Platform for Triple-Negative Breast Cancer.A Novel DNA Aptamer for Dual Targeting of Polymorphonuclear Myeloid-derived Suppressor Cells and Tumor Cells.Contribution of Kupffer cells to liposome accumulation in the liver.Extracellular vesicle therapeutics for liver disease.Taking the vehicle out of drug delivery.Multistage vector delivery of sulindac and silymarin for prevention of colon cancer.Polyethylene glycol (PEG)-dendron phospholipids as innovative constructs for the preparation of super stealth liposomes for anticancer therapy.Multi-step encapsulation of chemotherapy and gene silencing agents in functionalized mesoporous silica nanoparticles.Targeting the thyroid gland with thyroid-stimulating hormone (TSH)-nanoliposomes.Mechanistic features of nanodiamonds in the lapping of magnetic heads.Minimal information for studies of extracellular vesicles 2018 (MISEV2018): a position statement of the International Society for Extracellular Vesicles and update of the MISEV2014 guidelines
P50
Q26784324-41B316DF-2B73-42B5-8CDA-E5FDBB613841Q28083076-1B5AB527-2AA9-4DB7-8481-2DB0E8605CCDQ30569568-A942F329-0F2D-4331-8BFE-775ADF2D80D9Q30574647-DFED3091-B6A4-43BE-8FC6-38F24AA31661Q30585455-B5EE5E8A-0C68-4F00-8EB8-0C5BDCBF9E39Q30731671-E15D6121-B4A5-4704-B542-3D9F3B922AD7Q34122883-B08504BF-8239-4F08-B349-F075CFFE871DQ34276290-71460EE5-F997-4962-9BB9-CDC2FC106A87Q34502573-3CEFE1B6-706F-4536-A16A-8E55BC21A456Q35161952-231270E7-C195-4B26-AF4A-68534E87B336Q35628474-F72526DD-5F90-4982-9DD4-76E28827DB6DQ36307634-20AC4B22-BA12-4595-9B63-797EF9CE46BCQ36442577-0466C80F-AFE3-4E22-86A4-2E788A3A9EA5Q36813889-4354A124-DB6E-4B1B-A786-9A911DE63B27Q37303709-0BF19E01-836B-41A8-AF1E-C7A13EA01588Q37347110-10FCD307-7BFB-4BDC-A597-0A37267571C3Q37404528-D7BB54CE-F3A4-45E1-8615-1EC181B4136AQ37449547-B8A80141-EAA9-48E4-9AD9-D337EFEB7014Q38148788-10931C81-ED0E-4B11-83F3-976DBBE5C213Q38167883-2A11684D-5560-4E04-834A-AF9AD50F1459Q38236757-F3125390-C5A3-4ECA-BB3C-06E32A8FE2B5Q38824855-F5879D09-F28A-4777-8F5B-E7E3549ECEE9Q38899155-7F5B7DBD-CA7D-4154-8A80-1FEFDFCA866DQ38968910-913A53B9-029B-4FC7-A711-5384C071000BQ39085322-A13D2D88-2429-4303-BA04-6B0C43F535F2Q39410383-D835BCF9-061C-402C-84AD-AB65CDAF4969Q41112245-947D711A-F892-4113-BC6A-2C59517D2F01Q42645380-40F26B5B-169E-4A50-898C-EA87DE5AA351Q42695589-136BCDF6-3F3F-4C24-A7DE-4002396A787CQ42972230-36267F38-8520-4E78-A60B-5071564BE757Q47207633-23980C98-A2CC-4199-8927-E9D2B5CA4294Q48718420-33587B1D-36FC-4028-8B15-53AC838D1D91Q49649920-2DB47332-1160-4191-8DD0-0F4548DE40B1Q50437586-652843D6-452D-4E92-A6A6-4A1BA46D0DC2Q50552302-0EE519C3-4392-4EA8-BC41-ECC97ECF7CD7Q50615834-87D5BB42-CB24-4BDE-8B50-161933F290E1Q50921061-234611C8-99C9-44DF-935C-A97780A4B250Q51748703-F154E3BC-81F7-447B-A1A6-9B3B2EA1120CQ53496222-A01652A9-626D-48F1-AF24-526AAA40185AQ60326168-9364EB6C-16AF-4397-9BF6-43AA6B3882BA
P50
description
Finnish nanoscientist, PhD, assistant professor
@en
Fins assistent-professor
@nl
suomalainen nanotieteilijä, PhD, apulaisprofessori
@fi
name
Joy Wolfram
@ast
Joy Wolfram
@ca
Joy Wolfram
@en
Joy Wolfram
@es
Joy Wolfram
@fi
Joy Wolfram
@fr
Joy Wolfram
@ga
Joy Wolfram
@nl
Joy Wolfram
@sl
Joy Wolfram
@sq
type
label
Joy Wolfram
@ast
Joy Wolfram
@ca
Joy Wolfram
@en
Joy Wolfram
@es
Joy Wolfram
@fi
Joy Wolfram
@fr
Joy Wolfram
@ga
Joy Wolfram
@nl
Joy Wolfram
@sl
Joy Wolfram
@sq
altLabel
J Wolfram
@en
J-E V Wolfram
@en
J-E Wolfram
@en
J. Wolfram
@en
J.-E. V. Wolfram
@en
J.-E. Wolfram
@en
Joy Emelie (Joy) V. Wolfram
@en
Joy-Emelie V Wolfram
@en
Joy-Emelié V Wolfram
@en
Joy-Emelié V. Wolfram
@en
prefLabel
Joy Wolfram
@ast
Joy Wolfram
@ca
Joy Wolfram
@en
Joy Wolfram
@es
Joy Wolfram
@fi
Joy Wolfram
@fr
Joy Wolfram
@ga
Joy Wolfram
@nl
Joy Wolfram
@sl
Joy Wolfram
@sq
P106
P108
P1153
55376006600
P1960
ZjBJci8AAAAJ
P21
P2611
joy_wolfram
P27
P31
P496
0000-0003-0579-9897
P569
1989-01-01T00:00:00Z